Summary
Rats were given daily injections of 0.2 or 0.5 g/kg chlorophenoxyisobutyrate (clofibrate) for 9 to 46 days. Lower leg muscles were studied with light and electron microscopy.
Daily treatment with 0.5 g/kg of the drug for 26–46 days caused myopathic changes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bridgeman, J. F., Rosen, A. M., Thorp, J. M.: Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. LancetII, 502–506 (1972)
Denizot, M., Farre, J., Pometta, D., Wildi, E.: Clofibrate, nephrotic syndrome and histological changes in muscle. LancetI, 1326 (1973)
Green, K. G., Margetts, G.: Long-term follow-up of multicentre trial of ethyl-α-chlorophenoxyisobutyrate (clofibrate. “Atromid”-S) and clofibrate plus androsterone (“Atromid”). In: Progress in biochemical pharmacology, Vol. 2 (eds. D. Kritchevsky, R. Paoletti, D. Steinberg), pp. 378–392. Basel Karger 1967
Guth, L., Samaha, F. J.: Procedure for the histochemical demonstration of actomyosin ATPase. Exp. Neurol.28, 365–367 (1977)
Hess, R., Stäubli, W., Reiss, W., Reiss, W.: Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature208, 856–858 (1965)
Katsilambros, N., Braaten, J., Ferguson, B. D., Bradley, R. F.: Muscular syndrome after clofibrate. N. Engl. J. Med.282, 1110 (1972)
Langer, T., Levy, R. I.: Acute muscular syndrome associated with administration of clofibrate. N. Engl. J. Med.279, 856–858 (1968)
Luft, J. H.: Improvements in Epoxy resin embedding methods. J. biophys. biochem. Cytol9, 409–414 (1961)
Panini, S. R., Ramakrishna Kurup, C. K.: Mode of inhibition of mitochondrial energy transduction by chlorophenoxyisobutyrate. Biochem. J.142, 253–261 (1974)
Pearse, A. G.: Oxidoreductases. In: Histochemistry, III ed. London: Churchill Livingstone 1972
Pierides, A. M., Alvarez-Ude, F., Kerr, D. N. S., Skillein, A. W.: Clofibrate-induced muscle damage in patients with renal failure. LancetII, 1279 (1975)
Reynolds, E. S.: The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J. cell. Biol.17, 208–212 (1963)
Sabatini, D. D., Bensch, K., Barrnett R. J.: Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. J. cell. Biol.17, 19–58 (1963)
Smith, A. F., Macfie, W. G., Oliver, M. F.: Clofibrate, serum enzymes, and muscle pain. Brit. Med. J.2, 86–88 (1970)
Teräväinen, H., Larsen, A.: Electrophysiological and structural studies on the effects of clofibrate on the peripheral nerves and motor end-plates. (To be published.)
Watson, M. L.: Staining of tissue sections for electronmicroscopy with heavy metals. J. biophys. biochem. Cytol.4, 475–478 (1958)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Teräväinen, H., Larsen, A. & Hillbom, M. Clofibrate-induced myopathy in the rat. Acta Neuropathol 39, 135–138 (1977). https://doi.org/10.1007/BF00703319
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00703319